Fourth, the favorable combination of Tα1 with an anti-PD-1 antibody has been already postulated in an experimental setting in which low doses of Tα1, while being ineffective alone, increased the efficacy of an anti-PD-1 antibody in the lung metastasis melanoma model (30). The gene discussed is TAAR1; the disease is melanoma.